1. Epigenetics Apoptosis Cell Cycle/DNA Damage
  2. DNA Methyltransferase Apoptosis Nucleoside Antimetabolite/Analog
  3. Decitabine methanesulfonate

Decitabine methanesulfonate  (Synonyms: 5-Aza-2'-deoxycytidine methanesulfonate; 5-AZA-CdR methanesulfonate; NSC 127716 methanesulfonate)

Cat. No.: HY-A0004B
Handling Instructions Technical Support

Decitabine methanesulfonate (5-Aza-2'-deoxycytidine methanesulfonate) is an orally active Deoxycytidine analogue antimetabolite and DNA methyltransferase inhibitor. Decitabine methanesulfonate incorporates into DNA in place of cytosine can covalently trap DNA methyltransferase to DNA causing irreversible inhibition of the enzyme. Decitabine methanesulfonate induces cell G2/M arrest and cell Apoptosis. Decitabine has potent anticancer activity.

For research use only. We do not sell to patients.

CAS No. : 879492-57-6

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Other In-stock Forms of Decitabine methanesulfonate:

Other Forms of Decitabine methanesulfonate:

Top Publications Citing Use of Products

168 Publications Citing Use of MCE Decitabine methanesulfonate

RT-PCR
WB
Cell Proliferation/Viability Assay
IF

    Decitabine methanesulfonate purchased from MedChemExpress. Usage Cited in: Cell. 2024 Apr 25;187(9):2288-2304.e27.  [Abstract]

    SLC6A6 mRNA levels in the indicated cells treated with decitabine (1 μM for 3 days).

    Decitabine methanesulfonate purchased from MedChemExpress. Usage Cited in: Oxid Med Cell Longev. 2022 Mar 29;2022:2371807.  [Abstract]

    The toxicity of decitabine to Y79 and WERI-RB-1 cells is detected by CCK-8 assay at different concentrations of Decitabine.

    Decitabine methanesulfonate purchased from MedChemExpress. Usage Cited in: Oxid Med Cell Longev. 2022 Mar 29;2022:2371807.  [Abstract]

    The mRNA expression of GSDME is detected using RT-PCR after treatment with different concentrations of Decitabine for 3 days (the cells were centrifuged, and decitabine is replaced every day).

    Decitabine methanesulfonate purchased from MedChemExpress. Usage Cited in: Oxid Med Cell Longev. 2022 Mar 29;2022:2371807.  [Abstract]

    The protein level of GSDME in cells is quantitatively analysed by western blot in Y79 and WERI-RB-1 cells after Decitabine (2 nM; 3 days) treatment.

    Decitabine methanesulfonate purchased from MedChemExpress. Usage Cited in: Oxid Med Cell Longev. 2022 Mar 29;2022:2371807.  [Abstract]

    The protein level of GSDME in cells is detected using immunofluorescence in Y79 and WERI-RB-1 cells after Decitabine (2 nM; 3 days) treatment.

    Decitabine methanesulfonate purchased from MedChemExpress. Usage Cited in: Prog Neurobiol. 2021 Jun:201:102028.  [Abstract]

    The TF changes induced by DNMT3L in these cells are not affected with Decitabine (10 µM; for 24 hours) treatment in most genes tested, except NEUROD2 and NEUROG2 as shown by qRTPCR.

    Decitabine methanesulfonate purchased from MedChemExpress. Usage Cited in: Cell Prolif. 2021 Jul;54(7):e13072.  [Abstract]

    The indicated HSCs are subjected to DNMTs inhibitor (5‐azadC, 2 μM), G9a inhibitor (UNC0642, 2 μM) and pan‐HDAC inhibitor (ITF‐2357, 100 nM) for 48 h, or EZH2 inhibitor (EPZ‐6438, 10 μM) for 72h. KLF14 expression is measured by RT‐qPCR.

    Decitabine methanesulfonate purchased from MedChemExpress. Usage Cited in: Cell Prolif. 2021 Jul;54(7):e13072.  [Abstract]

    The indicated HSCs are subjected to DNMTs inhibitor (5‐azadC, 2 μM), G9a inhibitor (UNC0642, 2 μM) and pan‐HDAC inhibitor (ITF‐2357, 100 nM) for 48 h, or EZH2 inhibitor (EPZ‐6438, 10 μM) for 72h. KLF14 expression is measured by Western blotting analyses.

    Decitabine methanesulfonate purchased from MedChemExpress. Usage Cited in: Oncogene. 2020 Aug;39(33):5507-5519.  [Abstract]

    Quantitative real-time PCR analysis of CDH13 expression after 5 μM Decitabine treatment.

    Decitabine methanesulfonate purchased from MedChemExpress. Usage Cited in: J Invest Dermatol. 2020 Dec;140(12):2442-2454.e5.  [Abstract]

    In EZH2 mutant cells, after six days of drug treatment with both GSK126 and 0.5 μM Decitabine, Western blots shows complete elimination of H3K37me3 with reductions in DNMT1A, DNMT3A, and DNMT3B.

    Decitabine methanesulfonate purchased from MedChemExpress. Usage Cited in: J Invest Dermatol. 2020 Dec;140(12):2442-2454.e5.  [Abstract]

    In EZH2 mutant cells, after six days of drug treatment with both GSK126 and 0.5 μM Decitabine, Significant upregulation of RASSF5, EPAS1, ITGB2, and NDRG1 target gene expression is seen in EZH2 mutant cell lines.

    Decitabine methanesulfonate purchased from MedChemExpress. Usage Cited in: Ann Rheum Dis. 2019 Oct;78(10):1420-1429.  [Abstract]

    Western blot of PPARγ from mouse chondrocytes treated with IL-1β (10 ng/mL) for 24 hours in absence or presence 5Aza of various doses (0, 1, 5 and 10 µM).

    Decitabine methanesulfonate purchased from MedChemExpress. Usage Cited in: Ann Rheum Dis. 2019 Oct;78(10):1420-1429.  [Abstract]

    Western blot of PPARγ, MMP13, Aamts5, Aggrecan and Collagen2 from Sham, DMM and 5Aza-treated mouse joint tissues (0.35 mg/kg; intraperitoneal injection daily; 10 weeks).

    Decitabine methanesulfonate purchased from MedChemExpress. Usage Cited in: J Allergy Clin Immunol. 2019 Jun;143(6):2038-2051.e12.  [Abstract]

    Naive CD4+ T cells are stimulated with anti-CD3/CD28 in the presence of mock stimulant or Decitabine (5-aza-29-deoxycytidine; 1 µM). Real-time PCR analysis of Il4 and Il13 mRNA after 24 hours of stimulation and IL-4 and IL-13 concentrations in culture supernatants after 72 hours of stimulation are measured.

    View All DNA Methyltransferase Isoform Specific Products:

    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    Decitabine methanesulfonate (5-Aza-2'-deoxycytidine methanesulfonate) is an orally active Deoxycytidine analogue antimetabolite and DNA methyltransferase inhibitor. Decitabine methanesulfonate incorporates into DNA in place of cytosine can covalently trap DNA methyltransferase to DNA causing irreversible inhibition of the enzyme. Decitabine methanesulfonate induces cell G2/M arrest and cell Apoptosis. Decitabine has potent anticancer activity[1][2][3][4][5][6][7].

    In Vitro

    Decitabine methanesulfonate (96 h) treatment significantly inhibits cell growth of SNU719, NCC24 and KATOIII 96 hours after exposure to decitabine. Decitabine methanesulfonate induces G2/M arrest and apoptosis in EBVaGC, inhibits invasion ability, and up-regulates E-cadherin expression for EBVaGC[1].
    Only high concentrations (10 μM) Decitabine (0.1-10 μM; 24-72 h) methanesulfonate results in a G2 phase arrest, which is accompanied by a reduction of cells in G1 phase in HCT116 cells[3].
    Decitabine methanesulfonate up-regulates DCTPP1 and dUTPase expression in HeLa cells[4].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Cell Cycle Analysis[3]

    Cell Line: HCT116 cells
    Concentration: 0.1, 1, 10 µM
    Incubation Time: 24, 48, 72 hours
    Result: Only high concentrations (10 µM) resulted in a G2 phase arrest, which was accompanied by a reduction of cells in G1 phase.
    In Vivo

    Decitabine (1.0 mg/kg, p.o.) methanesulfonate in combination with tetrahydrouridine (THU) causes severe toxicity occurs in female CD-1 mice, and results in an increased sensitivity to decitabine toxicity correlating with decitabine plasma levels[5].
    Decitabine (1.0 mg/kg; i.p.; once daily for 5 consecutive days) methanesulfonate leads to regression of EL4 tumors established in C57BL/6 Mice[7].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: C57BL/6 mice (bearing EL4 cells)[7]
    Dosage: 1.0 mg/kg
    Administration: Intraperitoneal injection; once daily for 5 consecutive days
    Result: Caused continuous tumor regression even after Decitabine methanesulfonate treatment was stopped.
    Molecular Weight

    324.31

    Formula

    C9H16N4O7S

    CAS No.
    SMILES

    CS(=O)(O)=O.O=C1N(C=NC(N)=N1)[C@@H]2O[C@@H]([C@H](C2)O)CO

    Shipping

    Room temperature in continental US; may vary elsewhere.

    Storage

    Please store the product under the recommended conditions in the Certificate of Analysis.

    Purity & Documentation
    References
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    • Molarity Calculator

    • Dilution Calculator

    The molarity calculator equation

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass   Concentration   Volume   Molecular Weight *
    = × ×

    The dilution calculator equation

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
    × = ×
    C1   V1   C2   V2
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

     

    Requested Quantity *

    Applicant Name *

     

    Salutation

    Email Address *

     

    Phone Number *

    Department

     

    Organization Name *

    City

    State

    Country or Region *

         

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Decitabine methanesulfonate
    Cat. No.:
    HY-A0004B
    Quantity:
    MCE Japan Authorized Agent: